This is a second article in series of articles on the total error approach within the context of analytical method validation. If you missed the first article, I encourage you to read it to get familiar with the total error concept and what we are going to discuss below: https://www.linkedin.com/pulse/why-you-never-really-validate-your-analytical-method-use-de-marchin
Why you never really validate your analytical method unless you use the total error approach (part II: Producer and Consumer risks)
- PharmaLex
Disclaimer:
This blog is intended to communicate PharmaLex’s capabilities which are backed by the author’s expertise. However, PharmaLex US Corporation and its parent, Cencora, Inc., strongly encourage readers to review the references provided with this article and all available information related to the topics mentioned herein and to rely on their own experience and expertise in making decisions related thereto as the article may contain certain marketing statements and does not constitute legal advice.
Contact us for more information
Related Blog & Articles
Blog & Article
- 18th October 2024
Blog & Article
- 20th September 2024
Blog & Article
- 13th September 2024